stool pathogens, diarrhoea and the association with hiv.

NLM AIDSLINE Stool pathogens, diarrhoea and the association with HIV. Batchelor B; Brindle R; Kimari J; Paul J; Gilks C; Waiyaki P; Kenya
November 30, 1993

Int Conf AIDS. 1993 Jun 6-11;9(1):316 (abstract no. PO-B06-1083). Unique We retrospectively reviewed the results of 1986 stool samples submitted to the KEMRI/Wellcome Trust Research Programme microbiology laboratory between January 1989 and October 1992. 1806 stool samples were from HIV-positive patients and 164 from HIV-negative patients. All the patients were adults and had presented with GI symptoms. The laboratory received samples from hospital in-patients and from outpatient clinics within Nairobi. The patients were drawn from four separate studies. Specimens were cultured routinely for salmonella, shigella and campylobacter, samples taken during some studies were also cultured for yersinia and vibrios. Mycobacterial culture was performed using Kirchner's selective media and an aliquot of each samples was concentrated and examined for ova, cysts and parasites. Phenol-auramine stain and fluorescent microscopy was used to detect cryptosporidia. TABULAR DATA, SEE ABSTRACT VOLUME. Full details of the patient groups, laboratory methods and data analysis will be presented. AIDS-Related Opportunistic Infections/MICROBIOLOGY Diarrhea/MICROBIOLOGY Diarrhea/PARASITOLOGY Feces/MICROBIOLOGY *Feces/PARASITOLOGY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Too many patients, too little time After a decade, global AIDS program looks ahead South Africa: Mandela name pulled into politics General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Support Program Expansion CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Navajo Confront an Increase in New H.I.V. Infections TB, HIV and malaria vaccine research gets major boost Measuring hidden HIV
Information in this article was accurate in November 30, 1993. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.